Revolutionizing Rapid Testing: North America Point-of-Care Diagnostics Market Set to Soar Amid Rising Demand for Instant Healthcare Solutions 2025 | Top key players - QIAGEN, Trinity Biotech plc, BioMérieux SA.

The North America point-of-care diagnostics market size reached US$ 6.74 billion in 2024 and is expected to reach US$ 13.25 billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033.

The North America Point-of-Care Diagnostics Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/north-america-point-of-care-diagnostics-market?sz

The North America Point-of-Care Diagnostics Market refers to the segment of the healthcare industry focused on diagnostic testing performed at or near the site of patient care. These rapid tests enable timely clinical decision-making without the need for centralized laboratory facilities. The market includes products for infectious diseases, glucose monitoring, pregnancy testing, and other conditions across various healthcare settings.

Major players in the North America Point-of-Care Diagnostics Market

The prominent players in North America Point-of-Care Diagnostics market research report are: BD, QuidelOrtho Corporation, QIAGEN, Trinity Biotech plc, BioMérieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Danaher Corporation, and Nova Biomedical, among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Key Development

In February 2025, Avitia introduced an AI-powered platform designed to revolutionize rapid, point-of-care cancer testing. This cutting-edge technology equips laboratories and clinicians with advanced molecular diagnostics, enabling them to gain accurate cancer insights quickly and begin treatment sooner-all while significantly reducing costs and improving patient care.

In January 2025, Roche announced that its cobas liat STI multiplex assay panels received 510(k) clearance and CLIA waiver from the U.S. FDA. These point-of-care panels allow clinicians to detect and distinguish multiple sexually transmitted infections-including chlamydia, gonorrhea, and Mycoplasma genitalium-using a single sample. The approval enhances diagnostic speed and accuracy, helping providers deliver timely and targeted treatment.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/north-america-point-of-care-diagnostics-market

Market Segments

By Product: Infectious Disease Testing Products, Blood Glucose Products, Blood Gas & Electrolyte Products, Hematology Testing Products, Urinalysis Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Profiling Products, Drug-of-Abuse Products, Others.

By Technology: Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Microfluidics, Others.

By Application: Infectious Diseases, Hematology, Cardiology, Endocrinology, Oncology, Drug Testing, Neurology, Others.

By End-User: Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgery Centers (ASCs), Home Care Settings.

The North America Point-of-Care Diagnostics industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay ahead with data-driven strategies, competitive analysis, and future outlook.
👉 Get the Extensive Full Report Now: https://www.datamintelligence.com/buy-now-page?report=north-america-point-of-care-diagnostics-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.